Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/59482470-f572-4077-91d4-87b7ae1e07b6/

AHC

Austco Healthcare Limited
Chart
0.24 AUD
Latest Week 2026-07-10
HealthcareMedical Instruments & SuppliesMICRO
Snapshot 2026-07-12 · 0.6w · Fresh
0.8
OS Score
94.0%
Value
91.0%
Quality
5.0%
Momentum
3/9
F-Score
0.925
QV
StrategiesValueQualityMomentumCompositeInteractionsFactor AnalysisTrendsFundamentals
Strategy Eligibility
4 of 23 passing
★
OS Composite
OS 0.800
↗
Trending Value
✗
◆
Quality × Value
QV 0.925
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
✗
◇
VC2 Cheapest
✗
📐
EBITDA/EV
13.5%
◐
Veiled Value
✗
▣
Piotroski Bargains
✗
🔬
Quality Compounders
✗
📈
Consistent Earners
✗
🌱
GARP
Rev +40%
🔄
Shareholder Yield
✗
💰
High Yield
✗
🚀
Momentum Leaders
✗
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
✗
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
✗
⚡
Risk-Adj Momentum
✗
V
Value Analysis
Cheapness relative to fundamentals
94.0%ile
P/E
15.5×
P/S
1.1×
P/B
1.8×
E/P
0.1237
FCF Yield
0.107
EBITDA/EV
0.135
SH Yield
-0.005
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
10.00000000
/100 — 1=cheapest
VC2 (Trending Value)
15.00000000
/100
VC3 (Buyback)
15.00000000
/100
FCF yield of 10.7% is strong — the business generates significant free cash relative to price.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
91.0%ile
ROE
0.115
ROA
0.065
Net Margin
0.073
Op Margin
0.123
GPA
0.465
Current
1.56
F-Score
3/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
0.400
Earn Growth
-0.162
5yr Consist
No
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
5.0%ile
6M Return
-38.8%
12M Return
-30.0%
12-1 Mom
-35.7%
Risk-Adj
-0.70
Vol 252d
50.7%
Vol 60d
122.4%
↑ Expanding
Max DD 12M
-48.3%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
12-1 momentum of -36% signals a downtrend — price is moving against you. Near-term vol (122%) is expanding vs long-term (51%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.8
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare · 145 peers
Sector Value %ile
99.3%
Sector Quality %ile
91.1%
P/E z-score
-0.47
P/B z-score
-0.45
Sector Avg OS
39.8%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
VLS Vita Life Sciences Limited 98.0% 94.0% 97.0% 88.0%
SDI SDI Limited 96.0% 86.0% 89.0% 95.0%
AGN Argenica Therapeutics Limited 93.0% 82.0% 80.0% 81.0%
BB1 BLINKLAB FPO [BB1] 93.0% 81.0% 80.0% 81.0%
RGT Argent BioPharma Limited 93.0% 81.0% 80.0% 81.0%
ALC Alcidion Group Limited 93.0% 81.0% 79.0% 81.0%
ENP Entropy Neurodynamics Limited 92.0% 80.0% 78.0% 80.0%
ECS ECS Botanics Holdings Ltd 92.0% 80.0% 79.0% 80.0%
Factor Interactions
Value + Quality Intersection
Top-tier on both cheapness (94th) and quality (91th) — the O'Shaughnessy sweet spot, historically the strongest long-term combination.
Growth at Reasonable Price
Revenue growing 40% with P/E of 15×. Growth isn't fully priced in.
Falling Knife
Weak momentum (5th) despite looking cheap (94th value). Wait for momentum to stabilise.
Volatility Expanding
60-day vol (122%) significantly exceeds 252-day (51%). Near-term risk is elevated.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
B
71.5% avg (7 factors)
Quality
C
48.6% avg (6 factors)
Momentum
F
1.9% avg (4 factors)
Risk
D
32.2% avg (1 factors)
Momentum is weak, suggesting the market isn't yet buying this thesis. Patience required. Elevated risk profile — position sizing should reflect the higher volatility.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Score Trends6 snapshots
Factor Persistence6 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.800—6—
Value %ile0.940—6—
Quality %ile0.910—6—
Momentum %ile0.050—6—
F-Score3.000—6—
Confidence0.453—0—
Volatility0.507—6—
Value Lens2021-07-13 → 2026-07-12
P/E Ratio
Earnings Yield
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
P/E Ratio
15.48
Earnings Yield (E/P)
0.1237
Price / Sales
1.13
Price / Book
1.77
FCF Yield
10.7%
EBITDA / EV
13.5%
Sales Yield (1/P·S)
1.0024
Shareholder Yield
Div + net buyback / mktcap
-0.5%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
11.5%
Return on Assets
6.5%
Net Margin
7.3%
Operating Margin
12.3%
Gross Profit / Assets
Novy-Marx GPA
46.5%
Current Ratio
1.56
MomentumPrice trend strength over different horizons
6M Return
-38.8%
12M Return
-30.0%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
-35.7%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
-0.70
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
40.0%
Earnings Growth (YoY)
-16.2%
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
3
Buyback Yield
-0.5%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
10
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
15
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
15
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity